Malunga-nomhlaza / unyango / iziyobisi / izintso

Iziyobisi ezivunyiweyo kwizintso (i-Renal Cell) Umhlaza

Eli phepha liluhlu lweziyobisi zomhlaza ezivunywe nguLawulo lokutya kunye noLawulo lweeDrug (FDA) kwizintso (iseli yezintso) umhlaza. Uluhlu lubandakanya amagama aqhelekileyo kunye namagama egama. Amagama amachiza adibanisa nesishwankathelo soLwazi lweCancer yeziyobisi. Kunokubakho iziyobisi ezisetyenziswa kwizintso (isisele sezintso) somhlaza ezingadweliswanga apha.

Iziyobisi ezivunyiweyo kwizintso (i-Renal Cell) Umhlaza

Ummeli (Everolimus)

Ummeli weDisperz (Everolimus)

UAldesleukin

UAvastin (Bevacizumab)

Avelumab

Axitinib

IBavencio (Avelumab)

Bevacizumab

ICabometyx (iCabozantinib-S-Malate)

ICabozantinib-S-Malate

Everolimus

I-IL-2 (Aldesleukin)

I-Inlyta (Axitinib)

I-Interleukin-2 (Aldesleukin)

Ipilimumab

Isitshixo (Pembrolizumab)

Lenvatinib Mesylate

ILenvima (Lenvatinib Mesylate)

IMvasi (Bevacizumab)

INexavar (iSorafenib Tosylate)

INivolumab

I-Opdivo (Nivolumab)

IPazopanib Hydrochloride

IPembrolizumab

Iproleukin (Aldesleukin)

I-Sorafenib Tosylate

Ilitinib Malate

Sutent (iSunitinib Malate)

I-Temsirolimus

I-Torisel (iTemsirolimus)

IVotrient (iPazopanib Hydrochloride)

I-Yervoy (Ipilimumab)